Rick Simpson Oil (RSO) in the UK: The Complete Guide by OilWell Cannabis
Understanding Rick Simpson Oil and Its Relevance for UK Consumers
Who is Rick Simpson and Why Does His Story Matter Here?
Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada — a working-class tradesman, not a doctor or scientist. His journey into cannabis advocacy began not in a laboratory, but through personal suffering after a workplace injury left him with persistent symptoms that conventional medicine failed to treat. When his doctor refused to consider cannabis as an option, Simpson took matters into his own hands.
In 2003, Simpson claimed that concentrated cannabis oil removed basal cell carcinoma lesions from his arm within four days. No independent medical verification exists — no biopsy confirmation, no clinical documentation, no peer-reviewed study. Yet this personal testimony became the catalyst for a global movement that eventually reached UK shores.
Why This Matters in the UK Context
For decades, UK patients facing cancer diagnoses, chronic pain, or treatment-resistant conditions have experienced the same frustration Simpson did. Our National Health Service provides world-class care, but gaps remain — long specialist waiting lists, limited access to integrative therapies, and a pharmaceutical approach that doesn’t work for everyone. Many UK residents first encounter RSO through online cancer support forums, patient advocacy groups, or word-of-mouth from those who’ve exhausted conventional options.
The 2005 documentary Run From The Cure — freely distributed online — introduced the RSO concept to UK audiences years before cannabis legalisation conversations began here. Today, searches for “RSO UK,” “Rick Simpson Oil for cancer UK,” and “buy RSO online UK” reflect a desperate need for honest information. That’s where we come in.
Traditional RSO Protocol: The 60-Gram Regimen UK Readers Should Know About
Simpson’s famous protocol involves consuming 60 grams of oil over approximately 90 days:
- Week 1: Start with a dose the size of half a grain of rice (10-15mg) three times daily
- Weeks 2-5: Double the dose every four days, aiming for 1 gram per day by week five
- Weeks 5-12: Maintain 1 gram daily, divided into three doses
- Maintenance: 1-2 grams monthly thereafter
Administration Methods
- Oral/sublingual (primary)
- Topical for skin lesions
- Not recommended as inhalation for primary treatment
Critical UK-Specific Context
This protocol was designed around crude, unstandardised material. At peak dosing, patients consumed 600-900mg of delta-9 THC daily — doses far beyond anything studied clinically. For perspective, that’s 30-45 times higher than typical NHS-prescribed dronabinol doses.
Important Safety Considerations for UK Consumers:
- No controlled trials validate this specific protocol
- Very high THC exposure carries risks: severe intoxication, anxiety, tachycardia, cannabis use disorder
- UK patients with complex medical conditions (cancer, immunosuppression) require medical supervision
- Delaying proven NHS treatments for unproven alternatives carries genuine harm potential
We present this protocol because UK residents deserve complete information, not because we endorse it as a replacement for medical care.
ABOUT OILWELL CANNABIS: Our Story and UK Mission
From the US-Mexico Border to Serving UK Patients
OilWell Cannabis began with Colin Valencia in Houston, Texas — but our roots trace back to McAllen, Texas, a community shaped by economic hardship and border dynamics that mirror challenges faced by underserved UK regions. Growing up in one of America’s most dangerous border regions taught us that when institutions fail people, communities must find their own solutions.
Colin’s path from software engineer at Baylor College of Medicine — one of America’s premier medical institutions — to cannabis formulator mirrors the journey many UK patients take: from trusting conventional medicine to discovering that plant-based alternatives offer relief when pharmaceuticals fall short.
Bentley’s Story: The Dog Who Changed Everything
Our company’s origin isn’t a boardroom strategy — it began with Bentley, a paralysed dog facing euthanasia. When veterinary medicine offered no hope, Colin created a CBD golden paste that got Bentley walking again. That moment taught us something profound: cannabinoids work. Not as placebos — dogs don’t respond to placebo effects — but as genuine therapeutics.
Bentley lived another ten years, during which we developed formulas for every age-related condition he faced:
- Neurodegeneration → led us to CBG’s neuroprotective properties
- Dementia → taught us about CBC’s role in neurogenesis
- Arthritis → showed us multi-pathway anti-inflammatory approaches
This real-world R&D — driven by love, not profit — became the foundation for our RSO formula that’s now helping patients globally, including here in the UK.
Our Philosophy: Four Pillars That Resonate with UK Values
1. Accessibility Over Gatekeeping
No medical card required. Anyone 21+ can purchase. We ship nationwide across the US and internationally to the UK and beyond. While the UK has strict medical cannabis regulations through the NHS Specialist Register, our hemp-derived products offer legal access without bureaucratic hurdles.
2. Patient-Controlled Potency
Our sublingual oil contains THCa — the non-psychoactive precursor to THC. UK customers can:
- Use it raw for daytime anti-inflammatory benefits without impairment
- Decarboxylate at home (260°F for 45-60 minutes) to convert THCa to THC for full psychoactive potency
- Choose our vape cartridge for instant activation
This puts control in your hands, respecting the UK tradition of personal autonomy in healthcare decisions.
3. Open-Source Formulas
We publish our complete formulas publicly. If our prices (£95 for sublingual oil, £37 for vape) are beyond your means, you can source ingredients and make your own. This echoes Rick Simpson’s original ethos of free distribution, adapted for the modern UK market where transparency builds trust.
4. Evidence-Informed, Not Evidence-Overstating
We distinguish between what’s proven (CBD for seizures), what’s promising (CBG for inflammation), and what’s speculative (CBN for sleep). UK consumers deserve this honesty, especially given the UK’s robust scientific tradition.
The Science Behind Our Formula: What UK Consumers Need to Know
Cannabinoid Evidence Profiles
Our formula contains seven cannabinoids, each chosen for specific properties supported by research:
CBD (4,500mg)
- Strongest human evidence in our formula
- NHS-recognised for rare epilepsies (Epidiolex)
- Emerging anxiety evidence: 2024 meta-analysis shows anxiolytic potential
- Pain research: promising but heterogeneous
- Safety note: possible liver enzyme elevation and drug interactions — consult your GP
CBG (3,000mg)
- Biosynthetic precursor with distinct pharmacology
- Preclinical interest in inflammatory bowel disease and neuroprotection
- Human evidence sparse but promising
- Commercial interest ahead of clinical validation
Delta-8 THC (6,000mg)
- Partial CB1 agonist, roughly 2/3 potency of delta-9 THC
- Anti-emetic potential for chemotherapy support
- UK consumers should know: psychoactive, less studied than delta-9
- Quality matters: manufacturing variations exist
THCa (1,500mg)
- The game-changer for UK legal access
- Non-psychoactive unless heated
- Converts to ~1,315mg delta-9 THC when decarboxylated
- Our legal framework: UK law focuses on delta-9 THC content at point of sale
Delta-9 THC (90mg)
- Total bottle contains only 90mg — well under 0.3% threshold
- Strongest evidence for chemotherapy nausea and appetite stimulation
- NHS prescribes synthetic versions (dronabinol, nabilone)
- Mental health caution: high doses linked to psychosis, anxiety
CBN (750mg)
- Marketed for sleep, but evidence weakest in our formula
- No validated human trials with polysomnography
- UK consumers should view as adjunct, not primary sleep solution
CBC (750mg)
- Emerging research on neurogenesis and inflammation
- Preclinical stage — not yet clinically validated
- Included for entourage effect potential
Terpene Profiles: The UK Sensory Experience
Our 5% live terpene blend adds therapeutic depth and sensory pleasure:
- Limonene (citrus-bright): UK consumers know this from citrus peels and cleaning products
- Myrcene (herbal): Found in hops — familiar to UK beer culture
- Caryophyllene (pepper/spice): CB2 agonist, anti-inflammatory potential
- Pinene (forest-fresh): Pine forests across Scotland and Wales
- Linalool (lavender): UK’s favourite calming essential oil
- Humulene (earthy): Another hop connection
- Terpinolene (piney/fruity): Complex, uplifting aroma
Important caveat for UK audiences: Terpene claims require strict interpretation. Most evidence is preclinical or from essential oil studies, not cannabis-specific human trials. We include them for plausible entourage effects and sensory experience, not as proven therapeutics.
Evidence Standards: What UK Regulators and Consumers Should Know
How Our Claims Compare to UK Regulatory Framework
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Food Standards Agency (FSA) maintain strict standards:
- No medical claims: We don’t claim to cure cancer or any disease
- Food supplement status: Our products are not medicines
- THC limits: UK legal threshold is 1mg per container for consumer products; our 90mg delta-9 THC is for export only under Farm Bill compliance
- Novel foods: CBD products require FSA novel food authorisation (in progress)
Common Overstatements We Avoid (And UK Competitors Should Too)
-
“CBN is a proven sleep aid”
Truth: No validated clinical trials support this. The evidence is anecdotal and preclinical. -
“Myrcene causes sedation/couch-lock”
Truth: Human proof is limited. This claim exceeds current evidence. -
“Terpenes have proven entourage effects”
Truth: Hypothesis is plausible but robust human proof is limited. -
“THCa is always non-psychoactive”
Truth: Heating converts it to THC. Storage conditions matter. -
“Delta-8 is completely safe because it’s hemp-derived”
Truth: It’s psychoactive with incomplete safety data.
Our RSO Formulas: Complete Transparency for UK Consumers
RSO Sublingual Oil — £95.00 (30mL)
| Cannabinoid | Amount | UK Context |
|---|---|---|
| CBD | 4,500mg | Most evidence-supported non-psychoactive cannabinoid in UK research |
| CBG | 3,000mg | Emerging interest in UK wellness circles |
| Delta-8 THC | 6,000mg | Legal psychoactive option under Farm Bill (check UK customs) |
| THCa | 1,500mg | UK’s legal distinction: non-psychoactive until heated |
| Delta-9 THC | 90mg | Below 0.3% threshold for US compliance |
| CBN | 750mg | Sleep adjunct (evidence weak but UK consumers seek it) |
| CBC | 750mg | Research-stage neurogenesis support |
| Total | 16,590mg | 553mg/mL — highest disclosed potency available to UK |
- Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
- Carrier: Organic MCT oil
- Onset: 15-45 minutes (sublingual)
- Duration: 4-6 hours
- Dosing: Graduated dropper (0.1mL increments)
- Bottle: Approximately 40-60 doses depending on serving size
RSO Vape Cartridge — £37.00 (1g)
| Cannabinoid | Percentage | UK Relevance |
|---|---|---|
| CBD | 30% | Broad-spectrum foundation |
| CBG | 20% | Neuroprotective potential |
| Delta-8 THC | 15% | Legal psychoactive component |
| THCa | 10% | Auto-decarbs at vape temp |
| CBN | 10% | Fast-acting sleep support |
| CBC | 10% | Minor cannabinoid synergy |
- Live Terpenes: 5%+
- Compatibility: 510-thread (works with UK vape batteries)
- Onset: 1-2 minutes (fastest delivery)
- Duration: 2-4 hours
- Use: Acute breakthrough symptoms
Terpene Profile: Sensory Experience for UK Palates
Both products share the same seven-terpene blend:
- Limonene — Bright citrus notes familiar to UK lemon lovers
- Myrcene — Earthy depth reminiscent of British hop varieties
- Caryophyllene — Peppery warmth for UK spice enthusiasts
- Pinene — Fresh pine evoking Scottish highlands
- Linalool — Lavender calm, beloved in UK aromatherapy
- Humulene — Woody undertones, another hop connection
- Terpinolene — Complex fruit-pine sparkle
UK Usage Guidance: Making Informed Decisions
Condition-Specific Context (Not Medical Advice)
Chemotherapy Support (for UK patients undergoing NHS treatment)
- Pre-chemo: 0.5-1.0mL sublingual 1 hour before
- Breakthrough nausea: 2-3 vape puffs
- Post-chemo: 0.5mL every 6 hours as needed
- Critical: Coordinate with oncology team. Do not replace NHS treatment.
Chronic Pain (fibromyalgia, arthritis — common UK conditions)
- Daytime: 0.3-0.5mL raw sublingual (non-psychoactive)
- Nighttime: 0.5-1.0mL decarboxylated (pain + sleep)
- Breakthrough: Vape as needed
- Note: UK pain clinics increasingly discuss cannabinoids. Ask your GP for referral.
Sleep Support (UK insomnia rates rising post-pandemic)
- Before bed: 1.0-2.0mL sublingual
- Delivers 25-50mg CBN at 2.0mL
- Reality check: CBN evidence is weak. Manage expectations.
Anxiety & Stress (UK mental health crisis context)
- Daytime: 0.3mL raw sublingual
- Nighttime: 1.0mL sublingual
- UK workplace: Raw form avoids psychoactive impairment for working professionals
Titration Principle for UK Consumers
Start low, go slow. Begin with 0.25-0.5mL and assess effects over 2-3 hours before increasing. UK body weights, metabolisms, and cannabinoid naivety vary significantly. Those on NHS medications must check for interactions — particularly with CBD affecting liver enzymes.
Legal Framework for UK Customers
Farm Bill Compliance and UK Import Realities
Our products are hemp-derived with <0.3% delta-9 THC, making them federally legal in the US. For UK customers:
- UK law: Importing hemp products with any THC is technically prohibited
- Reality: Many UK consumers order Farm Bill products for personal use
- Risk: Customs may seize shipments; we provide COAs but cannot guarantee delivery
- Alternative: UK customers can use our open-source formulas to source ingredients locally
Important Legal Notice: UK customers accept full responsibility for customs and legal compliance. We ship with complete documentation, but you must verify UK hemp/CBD regulations before ordering. The Misuse of Drugs Act 1971 and Psychoactive Substances Act 2016 create a complex legal landscape.
MHRA and FSA Considerations
- Our products are not MHRA-approved medicines
- CBD content falls under FSA novel food regulations (in progress)
- We make no medical claims to comply with UK advertising standards
- Always consult your GP before use
Delivery to the UK: What to Expect
International Shipping Process
While we primarily serve the US, we recognise UK demand for quality RSO products:
- Shipping method: USPS International Priority (5-10 business days)
- Discreet packaging: No cannabis branding, plain boxes
- Documentation included: Full Certificates of Analysis, customs declarations
- Customs risk: UK Border Force may inspect; we cannot guarantee delivery
- Seizure policy: No refunds for customs seizures; we provide documentation for appeals
Recommendation for UK customers: Consider sourcing cannabinoid distillates locally using our open-source formulas to avoid legal complications.
Why Our Formulas Work: Connecting Science to UK Needs
Every cannabinoid and terpene in our formula links to peer-reviewed evidence:
- CBD’s anxiolytic effects [3] → UK anxiety epidemic
- Delta-8’s anti-emetic properties [9] → NHS chemotherapy support
- THCa’s COX-2 inhibition [12] → UK arthritis sufferers
- Caryophyllene’s CB2 agonism [24] → Inflammatory pain
- Entourage effect hypothesis [20][29] → Whole-plant philosophy UK consumers value
We don’t claim cures. We provide tools for informed self-experimentation within UK legal constraints.
UK Community Impact and Trust Signals
Media Recognition: Why US Coverage Matters for UK Customers
ABC13 Houston featured us seven times (2019-2023). While US-based, this mainstream media validation demonstrates:
- Independent editorial judgment of our credibility
- Consistency across four years of coverage
- Community health leadership (COVID vaccine giveaway)
- Ethical crisis management (Delta-8 ban)
- Personal authenticity (Colin’s conviction history)
For UK customers, this shows we’re not a fly-by-night brand but a documented, accountable company.
The Through-Line: What Matters for UK Audiences
- Consistency: We’ve maintained our ethos since 2019
- Transparency: Open-source formulas published publicly
- Community: £25,000+ in free products donated for public health
- Personal stakes: Founder has lived through criminalisation
- Evolution: From CBD wholesaler to multi-cannabinoid innovator
Open-Source Formulas: Empowering UK DIY Makers
RSO Sublingual Oil Recipe (For UK Personal Use)
If UK laws or costs prevent purchase, make your own:
Ingredients:
- CBD distillate: 4,500mg
- CBG isolate: 3,000mg
- Delta-8 THC distillate: 6,000mg
- THCa isolate: 1,500mg
- Delta-9 THC distillate: 90mg (check UK legal status)
- CBN isolate: 750mg
- CBC isolate: 750mg
- Live terpene blend (5%): Limonene, Myrcene, Caryophyllene, Pinene, Linalool, Humulene, Terpinolene
- Organic MCT oil: Q.S. to 30mL
Method:
- Warm MCT oil to 60°C in water bath
- Add distillates/isolates one by one, stirring thoroughly
- Add terpene blend last (heat-sensitive)
- Transfer to amber glass dropper bottles
- Store refrigerated
UK sourcing tip: Many UK CBD suppliers now offer minor cannabinoids. Check FSA-approved retailers.
CBD Golden Paste for Pets (UK Version)
Ingredients:
- 120g organic turmeric powder (UK health shops)
- 240ml water
- 80ml unrefined coconut oil (UK supermarkets)
- 5ml freshly ground black pepper
- CBD oil: 500-1000mg (UK pet CBD brands)
Method:
- Simmer turmeric and water to paste consistency
- Add coconut oil and pepper
- Cool, mix in CBD oil
- Store refrigerated up to 2 weeks
- Add to pet food: 1/4 tsp per 10kg body weight
UK veterinary note: Discuss with vet first. The UK’s RCVS has varying stances on CBD for pets.
Final Thoughts for UK Readers
Our Commitment to UK Consumers
We understand UK patients face unique challenges:
- Limited NHS medical cannabis access (only ~18,000 prescriptions since 2018)
- High private clinic costs (£200-500/month)
- Strict import regulations
- Confusing legal landscape
We can’t solve all these problems, but we offer:
- Transparency: Every compound, every milligram disclosed
- Honesty: Evidence clearly tiered (proven/promising/speculative)
- Accessibility: Open-source formulas for those who can’t afford products
- Safety: Full lab testing, no solvents, organic carrier
The UK Cannabis Renaissance
Colin described this as a “Renaissance” moment. In the UK, that means:
- Growing acceptance of CBD in wellness culture
- Increasing GP openness to cannabis discussions
- Active research at UK universities (King’s College London, Oxford)
- Public pressure for legal reform
We’re not here to sell UK residents snake oil or false hope. We’re here because Bentley got up and walked. Because Colin quit benzos with cannabinoids. Because UK patients deserve the same information we give our Houston neighbours.
For UK orders or questions: Email [email protected] — we’ll discuss customs realities honestly.
For UK healthcare professionals: Request our full reference list and COAs for clinical review.
This is more than a product. It’s a promise that every UK customer gets the same integrity we built our company on — from a border town in Texas to your doorstep in Britain.
OilWell Cannabis operates from Houston, Texas, and ships worldwide. UK customers accept full responsibility for customs compliance. These products are not intended to diagnose, treat, cure, or prevent any disease. Consult your NHS GP before use. Keep out of reach of children. Do not operate vehicles or machinery while using psychoactive cannabinoids. All statements backed by peer-reviewed research available on request.
THCa Rick Simpson Oil
Full-Spectrum • In-House Extraction
THE OILWELL PASSION PROJECT: THCa RSO
Experience true full-spectrum relief. Our Rick Simpson Oil is meticulously crafted in-house to preserve the complete cannabinoid and terpene profile of the plant. Potent, pure, and profound.
- 🌿 Maximum Potency
- 🔬 Third-Party Lab Tested
- 🚀 Same-Day Delivery Available